Standard Family Office LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Standard Family Office LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2022$2,0000.0%550.0%0.00%
-95.0%
Q2 2022$2,000
-33.3%
55
-17.9%
0.02%
-25.9%
Q4 2021$3,000
-83.3%
67
-72.7%
0.03%
+575.0%
Q1 2021$18,0000.0%2450.0%0.00%0.0%
Q4 2020$18,0002450.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 78,905$8,306,0007.65%
FORT, L.P. 157,584$16,589,0004.68%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 808,200$85,079,0004.39%
Strategic Global Advisors, LLC 81,432$8,572,0003.18%
Prince Street Capital Management LLC 48,700$5,127,0001.62%
Analyst IMS Investment Management Services Ltd. 31,438$3,309,0001.45%
Freestone Capital Holdings, LLC 84,900$8,937,0000.77%
RPG Investment Advisory, LLC 17,227$1,813,0000.61%
CLINTON GROUP INC 46,370$4,881,0000.28%
USA FINANCIAL FORMULAS 10,786$1,135,0000.28%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders